This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit |  Histology Marketplace:     

Home   History   Meeting Calendar   Career Center   Certification   Contact Us    



 




NSH NEWS

NSH Symposium/Convention Career Day
NSH
Students are you prepared for your future? Do you want to learn about and experience the extraordinary and unique areas of histology available to you after graduation? Join us for the 2014 NSH Career Day taking place during the 40th Annual Symposium/Convention in the Austin Convention Center. This a free event for NSH Student Members. Students can attend the Career Day only or register for the convention and make it a part of their schedule. This event will take place from 1-4:30 p.m. on Monday, Aug. 25 in the exhibit hall. Click here for more information.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




IHC Committee booth volunteers and convention guides needed
NSH
Volunteers are needed to help staff the NSH IHC Committee booth from 10:45 a.m.-1:30 p.m. or 4:30-6 p.m. on Monday, Aug. 25. This is a great opportunity to meet other attendees and to learn more about our committees. You will have flyers to hand out and an answer sheet to help you answer any questions that attendees may have. Please email kim@nsh.org if you are interested. You may volunteer for an hour or more, whatever works best for your schedule. Also there are spots open for convention guides and this is an easy way for you to get involved with NSH and to help out other attendees. Shifts last 30 minutes and are available Saturday-Wednesday. Click here to learn more.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


SPONSORED CONTENT


TOP STORIES


Congress delays implementation of ICD-10 for another year to placate physicians; delay could cost healthcare industry up to $6.6 billion
Dark Daily
By now, most clinical laboratory managers and pathologists know that the date for implementing ICD-10 was pushed back by one year. This happened when Congress enacted a temporary fix to the Medicare Sustainable Growth Rate with enactment of the Protecting Access to Medicare Act last April. Currently, the federal law calls for implementation of ICD-10 to happen on Oct. 1, 2015, according to a report published by Journal of AHIMA, a publication of the American Health Information Management Association. Despite this delay, some powerful medical associations remain opposed to the adoption of ICD-10. Among their objections is the substantial cost for physicians to move from ICD-9 to ICD-10.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Better Color Images, Less Effort
Datacolor CHROMACAL™ standardizes color reproduction in digital brightfield images.
• Save time; no need for Photoshop!
• Accelerated workflow and batch processing.
• Reliable, consistent, standardized color and brightness.
• Get the best image the first time, all the time.

 LEARN MORE
 ChromaCal…Empowering Science with Color Integrity
 


Genomic responses in mouse models greatly mimic human inflammatory diseases
Medical Xpress
Mouse models of human diseases are essential research tools that are widely used in the medical sciences to increase our understanding of the pathogenesis and pathophysiology of various diseases, and to search for cures. Despite the widespread use of mice as animal models of disease, in 2013, Seok et al. reported that mouse models poorly mimic human inflammatory diseases, such as severe burn injury, sepsis, and acute infection, in terms of gene expression, which has been cited more than 400 times since its publication only 18 months ago.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




FDA acts on lab tests developed in-house
The New York Times
The Food and Drug Administration announced it would start regulating medical laboratory testing, saying that tests used to make important treatment decisions must be vetted and validated before they go into use. The decision, long in coming, has been fiercely opposed by some laboratories and pathologists, who have said that regulation by the agency is unnecessary and would significantly increase the cost and time needed to develop tests, stifling innovation and depriving patients of some vital tools.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


Study estimates that hospitals in Europe miss nearly 40,000 cases of C. difficile infections annually due to lack of clinical suspicion or failure to order a clinical lab test
Dark Daily
Once again, the bar on the quality of care is being raised. This time it involves hospitals in Europe. A recently published study shows that hospitals across the continent are not properly diagnosing all the cases of Clostridium difficile associated with patients having diarrhea. Failure to diagnose or inadequate use of medical laboratory tests were cited by researchers as contributing to this situation. The European, multi-center, prospective, bi-annual point prevalence study of Clostridium difficile in hospitalized patients with diarrhea revealed that more than 39,000 cases of the hospital bug C. difficile go undetected each year.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




IN THE NEWS


False hope for new superbug treatments
By Mike Wokasch
The lack of effective treatments for antibiotic-resistant "superbugs" represents a serious global healthcare issue with potentially disastrous consequences. In the hopes of finding new treatments, a number of organizations and governments are struggling to secure and provide sufficient financial and nonfinancial incentives to encourage more research. Unfortunately, the fallacy of some of these initiatives is that more money, more companies and more compounds will not deliver the products we need.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  GBI Cost Effective Products

GBI Labs produces the largest selection of secondary detection kits, from single to multiple detection kits, with wide range host species. We provide FREE samples to 1st time users. Staining with our kits results in similar or better sensitivity than other detection kits on the market with 20%-30% cost less.
 


Researchers identify another potential ALS treatment avenue
Medical Xpress
A series of studies begun by Harvard Stem Cell Institute scientists eight years ago has lead to a report published recently that may be a major step forward in the quest to develop real treatments for amyotrophic lateral sclerosis, ALS, or Lou Gehrig's disease. The findings by Harvard professor of Stem Cell and Regenerative Biology Kevin Eggan and colleagues also has produced functionally identical results in human motor neurons in a laboratory dish and in a mouse model of the disease, demonstrating that the modeling of human disease with customized stem cells in the laboratory could someday relatively soon eliminate some of the need for animal testing.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Pancreatic cancer study finds new genetic risk markers
Medical News Today
After comparing the DNA of thousands of people with and without the disease, a new study has identified five genetic markers for pancreatic cancer that raise the risk for developing the deadly disease. The international consortium of scientists reports the findings in the journal Nature Genetics. The discovery is the result of a third project in a series of genome-wide association studies that began in 2006 under the auspices of the National Cancer Institute Cohort Consortium.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Russian researchers close to pre-clinical tests of Ebola vaccine
The Voice of Russia
A Russian vaccine against Ebola hemorrhagic fever is now undergoing pre-clinical tests, according to the head of the Russian consumer rights watchdog, Rospotrebnadzor, Anna Popova. "The vaccine is being developed by the Vector State Research Centre. As of today, it is in a stage of pre-clinical drug trials. The works are intensified now," Popova said.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Biomarker for head and neck cancers identified
News-Medical.net
Although mutations in a gene dubbed "the guardian of the genome" are widely recognized as being associated with more aggressive forms of cancer, researchers at the University of California, San Diego School of Medicine have found evidence suggesting that the deleterious health effects of the mutated gene may in large part be due to other genetic abnormalities, at least in squamous cell head and neck cancers.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Researchers examining new treatments for gastric cancer
By Dr. Afsaneh Motamed-Khorasani
Gastric cancer is the fourth-most common cancer in the world, but there has been a continuous fall in its incidence and mortality rates in developed countries in the past 50 years. This has been mainly due to dietary improvements and a decrease in chronic Helicobacter pylori infection. Yet the outcome in many Western countries remains poor with an overall five-year survival of 25 percent as compared to 70 percent in Japan.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    NSH Uniform Labeling of Slides and Blocks in Surgical Pathology — an update at the NSH Symposium/Convention (NSH)
Growth in high deductible health plans cause savvy clinical labs and pathology groups to collect full payment at time of service (Dark Daily)
Memory and learning deficits restored in Alzheimer's mouse models (Medical News Today)
Anti-cancer lymphatic drugs show potential (Medical Xpress)
Social networking at the #NSHSC (NSH)

Don't be left behind. Click here to see what else you missed.


 

Under the Microscope
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Ashley Whipple, Senior Content Editor, 469.420.2642   
Contribute news

This edition of Under the Microscope was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
July 31, 2014 Blast
July 30, 2014
July 23, 2014
July 22, 2014 Blast



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063